The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Eastman Chemical's revenues will grow 30.6% and EPS will increase 28.7%.
The average estimate for revenue is $2.38 billion. On the bottom line, the average EPS estimate is $1.57.
Last quarter, Eastman Chemical chalked up revenue of $2.17 billion. GAAP reported sales were 26% higher than the prior-year quarter's $1.72 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.19. GAAP EPS were -$0.36 for Q4 versus $0.09 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 15.2%, 340 basis points better than the prior-year quarter. Operating margin was 2.3%, 100 basis points better than the prior-year quarter. Net margin was -2.5%, 320 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $9.55 billion. The average EPS estimate is $6.41.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 195 members out of 222 rating the stock outperform, and 27 members rating it underperform. Among 64 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 60 give Eastman Chemical a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Eastman Chemical is outperform, with an average price target of $70.06.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Eastman Chemical to My Watchlist.